نتائج البحث - "Jessicca Rege"

1

Academic Journal

347 Clinical outcomes of ovarian cancer patients treated with ALKS 4230, a novel engineered cytokine, in combination with pembrolizumab: ARTISTRY-1 trial

المؤلفون: Lucy Gilbert, Jameel Muzaffar, David McDermott, Vamsidhar Velcheti, Anna Spreafico, Valentina Boni, Christopher Hoimes, Ira Winer, Seth Rosen, Quincy Chu, Olivier Dumas, Aman Chauhan, Arvind Chaudhry, Piotr Tomczak, Debora Bruno, Elizabeth Dorn, Jessicca Rege

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2051-1426

URL الوصول: https://doaj.org/article/5558dc32bb3f46a4a9c1044cc2c6eec4

View record in DOAJ

Full Text Finder

2

TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

المؤلفون: Thomas Herzog, John Hays, Kathleen Moore, Panagiotis Konstantinopoulos, Lucy Gilbert, Bradley Monk, David O’Malley, Joyce Barlin, Jessicca Rege, Monali Desai, Yangchun Du, Rita Dalal, Robert L Coleman, Jalid Sehouli

المصدر: E-Posters (Trials In Progress).

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e646e600bd52f3c4083a72af54e152b4
https://doi.org/10.1136/ijgc-2022-igcs.534

View record in OpenAIRE

3

Initial safety run-in findings with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer

المؤلفون: Ian Chau, Haeseong Park, Johanna C. Bendell, Kerry Culm-Merdek, Jeeyun Lee, Jessicca Rege

المصدر: Journal of Clinical Oncology. 38:e16537-e16537

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bavituximab, business.industry, medicine.drug_class, Pembrolizumab, Phosphatidylserine, Monoclonal antibody, chemistry.chemical_compound, Gastroesophageal cancer, chemistry, Internal medicine, medicine, In patient, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fb0b1d6edbebf40bea63d2ba4c04aa4c
https://doi.org/10.1200/jco.2020.38.15_suppl.e16537

View record in OpenAIRE

4

A global phase II trial-in-progress with bavituximab plus pembrolizumab in patients with advanced gastric or gastroesophageal cancer

المؤلفون: Ian Chau, Johanna C. Bendell, Kerry Culm-Merdek, Jeeyun Lee, Jessicca Rege, Andrew William Pippas

المصدر: Journal of Clinical Oncology. 38:TPS459-TPS459

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Bavituximab, business.industry, Cancer, Pembrolizumab, medicine.disease, Gastroesophageal cancer, Internal medicine, medicine, In patient, Accelerated approval, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::937c5a1adc457f15aaef51160e891147
https://doi.org/10.1200/jco.2020.38.4_suppl.tps459

View record in OpenAIRE

5

Ramucirumab plus pembrolizumab in previously treated advanced or metastatic biliary tract cancer: A multi-disease phase 1 study

المؤلفون: Hendrik-Tobias Arkenau, Jin Jin, Ian Chau, Johanna C. Bendell, Gu Mi, Roy S. Herbst, Jessicca Rege, David Ferry

المصدر: Annals of Oncology. 28:iii144-iii145

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Biliary tract cancer, business.industry, Hematology, Disease, Pembrolizumab, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, Previously treated

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fd6175b9c363698dac9b205dec9340b0
https://doi.org/10.1093/annonc/mdx262.018

View record in OpenAIRE

6

Previously treated advanced NSCLC cohort from a multi-disease phase 1 study of ramucirumab (R) plus pembrolizumab (P): Efficacy and safety data

المؤلفون: Gu Mi, Johanna C. Bendell, Juan Martin-Liberal, Luis Paz-Ares, Emiliano Calvo, Jin Jin, Nicolas Isambert, Jessicca Rege, Philippe A. Cassier, Roy S. Herbst

المصدر: Annals of Oncology. 28:ii32-ii33

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Hematology, Disease, Pembrolizumab, Ramucirumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Cohort, Medicine, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b8c3d5c3b576a8539429c3b7675b57ee
https://doi.org/10.1093/annonc/mdx091.010

View record in OpenAIRE

7

Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study

المؤلفون: Emiliano Calvo, Rafael Santana-Davila, Jin Jin, Hendrik-Tobias Arkenau, Gu Mi, Roy S. Herbst, David Ferry, Ian Chau, Johanna C. Bendell, Charles S. Fuchs, Jessicca Rege

المصدر: Journal of Clinical Oncology. 35:4046-4046

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::107a49947fd9a23d37b86b1d5d1c78bf
https://doi.org/10.1200/jco.2017.35.15_suppl.4046

View record in OpenAIRE

8

A multicohort phase I study of ramucirumab (R) plus pembrolizumab (P): Interim safety and clinical activity in patients with urothelial carcinoma

المؤلفون: Daniel P. Petrylak, David Ferry, Jose Luis Perez-Gracia, Roy S. Herbst, J. Yang, Jessicca Rege, Matthew G Krebs, Gu Mi, Rafael Santana-Davila, Hendrik-Tobias Arkenau

المصدر: Journal of Clinical Oncology. 35:349-349

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::04dc2b0434c77419f369441d500809ae
https://doi.org/10.1200/jco.2017.35.6_suppl.349

View record in OpenAIRE

9

Interim safety and clinical activity in patients (pts) with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma from a multicohort phase 1 study of ramucirumab (R) plus pembrolizumab (P)

المؤلفون: Emiliano Calvo, Jordi Rodon Ahnert, David Ferry, Nicolas Penel, Roy S. Herbst, Jessicca Rege, Ian Chau, Gu Mi, Johanna C. Bendell, J. Yang, Charles S. Fuchs, Hendrik-Tobias Arkenau, Rafael Santana-Davila

المصدر: Journal of Clinical Oncology. 35:102-102

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::104062717632e28b94ec8597ccf7a036
https://doi.org/10.1200/jco.2017.35.4_suppl.102

View record in OpenAIRE

10

Interim safety and clinical activity in patients with advanced NSCLC from a multi-cohort phase 1 study of ramucirumab (R) plus pembrolizumab (P)

المؤلفون: Jessicca Rege, Emiliano Calvo, Jose Luis Perez-Gracia, David Ferry, Philippe A. Cassier, Nicolas Isambert, Johanna C. Bendell, J. Yang, Roy S. Herbst, Juan Martin-Liberal, Luis Paz-Ares, Gu Mi

المصدر: Annals of Oncology. 27:vi574

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, Pembrolizumab, Ramucirumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Interim, Cohort, Medicine, In patient, business, 030215 immunology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2aa507651b8a60288e2f1e7ec8497826
https://doi.org/10.1093/annonc/mdw435.34

View record in OpenAIRE

11

A phase 1 study of ramucirumab (R) plus pembrolizumab (P) in patients (pts) with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma, non-small cell lung cancer (NSCLC), or urothelial carcinoma (UC): Phase 1a results

المؤلفون: Gu Mi, David Ferry, J. Yang, Philippe A. Cassier, Emiliano Calvo, Rafael Santana-Davila, Roy S. Herbst, Jose Luis Perez-Gracia, Ian Chau, Johanna C. Bendell, Jessicca Rege, Nicolas Isambert

المصدر: Journal of Clinical Oncology. 34:3056-3056

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::99f1c30761acc2b7f57c120b21a62a34
https://doi.org/10.1200/jco.2016.34.15_suppl.3056

View record in OpenAIRE

12

Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe

المؤلفون: Greg Wolfe, Jessicca Rege, Natalia M. Flores, Andrew G. Gianoukakis, Anna Forsythe, Matthew H. Taylor, Marco DiBonaventura, C Pelletier

المصدر: Value in Health. 17:A614

مصطلحات موضوعية: Pathology, medicine.medical_specialty, Refractory, business.industry, Health Policy, Western europe, Internal medicine, Public Health, Environmental and Occupational Health, Medicine, Health outcomes, business, medicine.disease, Thyroid cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b69622f37c66c229e8517f0e027bb0c
https://doi.org/10.1016/j.jval.2014.08.2159

View record in OpenAIRE

13

Eribulin mesylate (Erib) plus capecitabine (X) for adjuvant treatment in post-menopausal estrogen receptor–positive (ER+) early-stage breast cancer: Phase II, multicenter, single-arm study

المؤلفون: David Cox, Hina Maniar, James Song, Joyce O'Shaughnessy, Jessicca Rege, John W. Smith

المصدر: Journal of Clinical Oncology. 31:563-563

مصطلحات موضوعية: Eribulin Mesylate, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Urology, Estrogen receptor, medicine.disease, Capecitabine, Regimen, Breast cancer, Oncology, medicine, Clinical endpoint, Stage (cooking), business, Nuclear medicine, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c5f23c4ec3ce2a4a1c3cc9496419677e
https://doi.org/10.1200/jco.2013.31.15_suppl.563

View record in OpenAIRE

14

A phase II, single-arm, feasibility study of dose-dense doxorubicin and cyclophosphamide (AC) followed by eribulin mesylate for the adjuvant treatment of early-stage breast cancer (EBC)

المؤلفون: Tiffany A. Traina, Jessicca Rege, David Cox, Robert Lehman, Andrew D. Seidman, Wenquan Wang, Clifford A. Hudis

المصدر: Journal of Clinical Oncology. 30:TPS1145-TPS1145

مصطلحات موضوعية: Eribulin Mesylate, Oncology, Cancer Research, medicine.medical_specialty, Taxane, Anthracycline, Cyclophosphamide, business.industry, medicine.medical_treatment, Pharmacology, medicine.disease, law.invention, Breast cancer, Randomized controlled trial, law, Internal medicine, medicine, Doxorubicin, business, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::7146a88f3628195fc38f4e35915a5800
https://doi.org/10.1200/jco.2012.30.15_suppl.tps1145

View record in OpenAIRE

تنقيح النتائج